 |
|
Typhoid Fever in the United States, 1999-2006
Michael F. Lynch, MD, MPH;
Elizabeth M. Blanton, MPH;
Sandra Bulens, MPH;
Christina Polyak, MD, MPH;
Jazmin Vojdani, MPH;
Jennifer Stevenson, MPH, PhD;
Felicia Medalla, MD;
Ezra Barzilay, MD;
Kevin Joyce, BS;
Timothy Barrett, PhD;
Eric Daniel Mintz, MD, MPH
JAMA. 2009;302(8):859-865.
Context Typhoid fever in the United States has increasingly been due to infection with antimicrobial-resistant Salmonella ser Typhi. National surveillance for typhoid fever can inform prevention and treatment recommendations.
Objective To assess trends in infections with antimicrobial-resistant S Typhi.
Design Cross-sectional, laboratory-based surveillance study.
Setting and Participants We reviewed data from 1999-2006 for 1902 persons with typhoid fever who had epidemiologic information submitted to the Centers for Disease Control and Prevention (CDC) and 2016 S Typhi isolates sent by participating public health laboratories to the National Antimicrobial Resistance Monitoring System Laboratory at the CDC for antimicrobial susceptibility testing.
Main Outcome Measures Proportion of S Typhi isolates demonstrating resistance to 14 antimicrobial agents and patient risk factors for antimicrobial-resistant infections.
Results Patient median age was 22 years (range, <1-90 years); 1295 (73%) were hospitalized and 3 (0.2%) died. Foreign travel within 30 days of illness was reported by 1439 (79%). Only 58 travelers (5%) had received typhoid vaccine. Two hundred seventy-two (13%) of 2016 isolates tested were resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole (multidrug-resistant S Typhi [MDRST]); 758 (38%) were resistant to nalidixic acid (nalidixic acid–resistant S Typhi [NARST]) and 734 NARST isolates (97%) had decreased susceptibility to ciprofloxacin. The proportion of NARST increased from 19% in 1999 to 54% in 2006. Five ciprofloxacin-resistant isolates were identified. Patients with resistant infections were more likely to report travel to the Indian subcontinent: 85% of patients infected with MDRST and 94% with NARST traveled to the Indian subcontinent, while 44% of those with susceptible infections did (MDRST odds ratio, 7.5; 95% confidence interval, 4.1-13.8; NARST odds ratio, 20.4; 95% confidence interval, 12.4-33.9).
Conclusion Infection with antimicrobial-resistant S Typhi strains among US patients with typhoid fever is associated with travel to the Indian subcontinent, and an increasing proportion of these infections are due to S Typhi strains with decreased susceptibility to fluoroquinolones.
Author Affiliations: Enteric Diseases Epidemiology Branch (Drs Lynch, Polyak, Stevenson, Medalla, Barzilay, and Mintz and Mss Blanton, Bulens, and Vojdani), Enteric Diseases Laboratory Branch (Mr Joyce and Dr Barrett), Division of Foodborne, Bacterial and Mycotic Diseases, and Office of the Chief Science Officer (Dr Barrett), National Center for Zoonotic Vector-borne and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
Addressing the Global Disease Burden of Typhoid Fever
Zulfiqar A. Bhutta and John Threlfall
JAMA. 2009;302(8):898-899.
EXTRACT
| FULL TEXT
Typhoid Fever
Huan J. Chang, Cassio Lynm, and Richard M. Glass
JAMA. 2009;302(8):914.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Addressing the Global Disease Burden of Typhoid Fever
Bhutta and Threlfall
JAMA 2009;302:898-899.
FULL TEXT
Typhoid Fever in the U.S.
JWatch Infect. Diseases 2009;2009:1-1.
FULL TEXT
|
